Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"prevalence"

Slides: 1–12 of 79
Add to tray Remove from tray

Background: Characteristics of Osteoarthritis

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: background | prevalence | characteristics
Add to tray Remove from tray

Rating the Strength of Evidence From the CER

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative effectiveness | strength of evidence | systematic review | methods
Add to tray Remove from tray

Background: Prevalence

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: prevalence | hypertension | risk factor | heart | kidneys
Add to tray Remove from tray

Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: research evidence | comparative effectiveness review
Add to tray Remove from tray

Background: Musculoskeletal Pain

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | children | clinical characteristics | stiffness | joint swelling | malar rash | cytopenia | pediatric rheumatic condition
Add to tray Remove from tray

Background: Pediatric Lupus Erythematosus

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: pediatric systemic lupus erythematosus | autoimmune disease | inflammation | blood vessels | connective tissues | organs | incidence | prevalence | disease progression | immunosuppression
Add to tray Remove from tray

Background: Cyclic-Citrullinated Peptide Antibody Test

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: autoantibodies | inflammatory arthritis | juvenile idiopathic arthritis | rheumatoid arthritis | cyclic-citrullinated peptide antibody test
Add to tray Remove from tray

Clinical Questions Addressed by the CER (1 of 3)

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: key questions | clinical questions | prevalence | incidence | natural history | musculoskeletal pain | children | adolescents
Add to tray Remove from tray

Report Findings: Prevalence of Musculoskeletal Pain Among Healthy Children

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | nontraumatic pain | prevalence | healthy children | healthy adolescents | age | sex | headache | abdominal pain | recurrence predictors
Add to tray Remove from tray

Report Findings: Etiology of Musculoskeletal Pain Among Healthy Children

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | healthy children | etiology | physical trauma | overuse | osteochondroses | hypermobility | growing pain | viral infection | prevalence
Add to tray Remove from tray

Report Findings: Prevalence of Positive Serological Test Results Among Healthy Children

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: healthy children | prevalence | positive test result | serological test | antinuclear antibody | rheumatoid factor | cyclic-citrullinated peptide antibody
Add to tray Remove from tray

Conclusions (1 of 2)

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: adolescents | age | children | clinical assessment | juvenile idiopathic arthritis | noninflammatory pain | prevalence | sex | test sensitivity | test specificity | musculoskeletal pain
Pages: [1] 2 3 4 5 6 7 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364